Skip to Main Content

Suzanne Rosenberg's proposal funded!

December 4, 2014 2:44 PM
Suzanne Rosenberg’s “Recombinant Bi-specific Cytotoxic Lymphocyte-activating Polypeptides for Tumor Immunotherapy” project submitted to the UMBC Techology Catalyst Fund is funded in full.
1 Comment (requires login)